30 Day Trial

Vericel Reports 4Q18 MACI Revenue of $25.1MM, +56% vs. 4Q17

Share:

Vericel reports 4Q18 MACI revenue of USD $25.1MM, +56% vs. 4Q17, with 2018 full year revenue of $67.7MM, +54.2% vs. 2017.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.